Signal Transduction and Targeted Therapy volume 9, Article number: 319 (2024) Cite this article.
Get the latest international news and world events from around the world.
Blood test can to identify cancer in patients with non-specific symptoms
The researchers then developed a model that can distinguish patients with cancer from those with other conditions, such as inflammatory, autoimmune or infectious diseases, with high precision.
“A particular strength of the study is that the control group consisted largely of patients with other serious conditions that can cause symptoms similar to cancer,” says the principal investigator for the study. “This reflects the clinical reality, where patients with non-specific symptoms are often difficult to assess.”
The researchers emphasise that the method should not replace imaging diagnostics or biopsies, but rather serve as a support for prioritising which patients should be investigated further. ScienceMission sciencenewshighlights.
A simple blood test can help detect cancer in patients with non-specific symptoms such as fatigue, pain or weight loss. This is according to a study published in Nature Communications.
When patients seek care for non-specific symptoms such as fatigue, pain or weight loss, it is often difficult to determine whether the cause is cancer, another serious condition or something completely harmless. In a new study, researchers have investigated whether proteins in the blood can provide early clues.
The study analysed blood samples from nearly 700 patient and the samples were taken before the diagnostic investigation began. Using proteomics, a method for large-scale protein analysis, the levels of 1,463 different proteins in plasma were measured. The researchers identified a specific combination of proteins, known as a protein signature, that could be linked to a cancer diagnosis.
Anticoagulation for the treatment of septic cerebral venous sinus thrombosis in the setting of pediatric sinogenic and otogenic intracranial infections
Schematic overview of the relationship between sinusitis, otitis media and/or mastoiditis, intracranial infection, and septic CVST. Management strategies include surgical washout of the infection, parenteral antibiotics, and hydration, although the role of anticoagulation remains controversial.
Septic cerebral venous sinus thrombosis (CVST) is a recognized complication of pediatric sinogenic and otogenic intracranial infections. The optimal treatment paradigm remains controversial. Proponents of anticoagulation highlight its role in preventing thrombus propagation and promoting recanalization, while others cite the risk of hemorrhagic complications, especially after a neurosurgical procedure for an epidural abscess or subdural empyema. Here, the authors investigated the diagnosis, management, and outcomes of pediatric patients with sinogenic or otogenic intracranial infections and a septic CVST.
All patients 21 years of age or younger, who presented with an intracranial infection in the setting of sinusitis or otitis media and who underwent neurosurgical treatment at Connecticut Children’s, Rady Children’s Hospital–San Diego, or Ann and Robert H. Lurie Children’s Hospital of Chicago from March 2015 to March 2023, were retrospectively reviewed. Demographic, clinical, and radiological data were systematically collated.
Ninety-six patients were treated for sinusitis-related and/or otitis media–related intracranial infections during the study period, 15 (15.6%) of whom were diagnosed with a CVST. Of the 60 patients who presented prior to the COVID-19 pandemic, 6 (10.0%) were diagnosed with a septic CVST, whereas of the 36 who presented during the COVID-19 pandemic, 9 (25.0%) had a septic CVST (p = 0.050). The superior sagittal sinus was involved in 12 (80.0%) patients and the transverse and/or sigmoid sinuses in 4 (26.7%). Only 1 (6.7%) patient had a fully occlusive thrombus. Of the 15 patients with a septic CVST, 11 (73.3%) were initiated on anticoagulation at a median interval of 4 (IQR 3–5) days from the most recent neurosurgical procedure. Five (45.5%) patients who underwent anticoagulation demonstrated complete recanalization on follow-up imaging, and 4 (36.4%) had partial recanalization. Three (75.0%) patients who did not undergo anticoagulation demonstrated complete recanalization, and 1 (25.
A process thought to destroy brain cells might actually help them store data
To ensure these laboratory-created fibers were the same as those found in living brains, the team utilized cryogenic electron microscopy (cryo-EM). This advanced imaging technique allows scientists to see the atomic structure of proteins.
The images revealed that the Orb2 amyloids created with the help of Funes were structurally identical to endogenous Orb2 amyloids extracted from fly heads. They possessed the same “cross-beta” architecture that characterizes functional amyloids.
The study further demonstrated that the “J-domain” of the Funes protein is essential for this activity. This domain is a specific section of the protein sequence that defines the JDP family.
What It’s Like To Be A Worm
Finding evidence of is fraught, whether in a comatose patient, an animal, or a neural net.
The Immune Chain Reaction That Raises Colon Cancer Risk in IBD
A hidden immune cascade linking the gut and bone marrow may explain how IBD turns inflammation into colon cancer.
Scientists at Weill Cornell Medicine have identified a complex immune process in the gut that may help explain why people with inflammatory bowel disease (IBD) face a much higher risk of colorectal cancer. The preclinical study shows how a specific immune signal can trigger a wave of white blood cells from the bone marrow into the gut, creating conditions that support tumor growth. The findings also suggest new approaches for detecting disease activity, tracking risk, and developing future treatments.
The role of TL1A in gut inflammation.
